Life ScienceCompany
Aralez Pharmaceuticals M&A Summary
Aralez Pharmaceuticals has acquired 3 companies of its own. It has also divested 2 assets.
Aralez Pharmaceuticals’ largest acquisition to date was in 2016, when it acquired AstraZeneca - Toprol-XL for $175M. It’s largest disclosed sale occurred in 2018, when it sold Aralez Pharmaceuticals - VIMOVO Royalties to Nuvo Pharmaceuticals for $110M. Aralez Pharmaceuticals has acquired in 1 US state, and 3 countries. The Company’s most targeted sectors include life science (67%) and healthcare services (34%).
Aralez Pharmaceuticals Ownership
Who owns Aralez Pharmaceuticals?
Aralez Pharmaceuticals is owned by Nuvo Pharmaceuticals. It was acquired on August 10, 2018.
Aralez Pharmaceuticals Business Overview
Where is Aralez Pharmaceuticals headquartered?
Aralez Pharmaceuticals is headquartered in Milton, Ontario.
What is Aralez Pharmaceuticals’ revenue?
Aralez Pharmaceuticals disclosed revenue of 106M USD for 2017 and 54M USD for 2016.
How many employees does Aralez Pharmaceuticals have?
Aralez Pharmaceuticals has 164 employees.
What sector is Aralez Pharmaceuticals in?
Aralez Pharmaceuticals is a life science company.
When was Aralez Pharmaceuticals founded?
Aralez Pharmaceuticals was founded in 2015.
M&A Summary
-
M&A Total Activity5
- M&A Buy Activity3
- M&A Sell Activity2
- Total Sectors Invested 2
- Total Countries Invested 3
- M&A Buy/Sell Connections 1
Unlimited Searches
